The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.81 (10.20%)
Spread: 0.50 (5.882%)
Open: 8.25
High: 8.75
Low: 8.25
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MicroSalt Partnership with Weijohn Farms Group

19 Sep 2023 07:00

RNS Number : 8303M
Tekcapital plc
19 September 2023
 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

19 September 2023

Tekcapital Plc

("Tekcapital")

 

MicroSalt® Launches Partnership with Weijohn Farms Group

To Provide its Full Flavor Low-Sodium Salt

 

Tekcapital Plc (AIM: TEK) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to announce that its portfolio company Microsalt Ltd ("Microsalt") has announced a partnership with Weijohn Farms Group, a multi-faceted organization that includes Sorbatto Fresh and Washington Organic Hazelnuts. Weijohn Farms Group will be using MicroSalt on its Sorbatto Fresh line of hazelnuts.

"The integration of MicroSalt into our salted product lines has been beneficial on multiple fronts. Not only does it offer our consumers a low-sodium yet flavorful option, but from an operational standpoint, MicroSalt has proven its ability to improve product adherence and general housekeeping," said Jeff Weijohn, owner of the Weijohn Farms Group.

Sorbatto Fresh hazelnuts. Photo courtesy https://www.sorbattofresh.com/

 

Rick Guiney, CEO of MicroSalt®, commented:

"We are very excited about our partnership with the Weijohn Farms Group and their Sorbatto Fresh brand. Excess sodium consumption is one of the leading contributors to hypertension and heart disease. Partnerships like this are the best way to provide consumers with great tasting, healthy products with less sodium."

Market Size

The North American hazelnut market was US$ 1.8 billion in 2022 and is projected to grow to US$ 3.2 billion by 2030 with a CAGR of 7.6%[1]. The expanding health benefits of eating hazelnuts are predicted to fuel substantial demand over the forecast period. Hazelnuts are regarded as a rich source of vitamins B, E, and K and are known for providing good lipids, proteins, and minerals. Furthermore, hazelnuts may help lower cholesterol levels. As a result, they are popular amongst health-conscious adults.

 

About Weijohn Farms Group & Sorbatto Fresh

The Weijohn Family has a rich farming history, spanning four generations in the Yakima Valley and has played an instrumental role in pioneering the hazelnut industry in Eastern Washington. Among other health benefits, hazelnuts contribute to increased oxidative capacity and reduced blood lipid levels, thereby helping to mitigate the risk of heart disease. Additionally, they are shown to help normalize blood pressure. To learn more about the Sorbatto Fresh brand please visit https://www.sorbattofresh.com/

 

About MicroSalt

MicroSalt is dedicated to innovating food technology solutions that enable people to live longer, healthier, and happier lives. Its patented low-sodium salt delivers natural salt with approximately 50% less sodium and may be used by both consumers and food manufacturers who wish to decrease the amount of sodium in their food. MicroSalt is 100% natural, non-GMO, gluten free, Kosher and contains no potassium chloride. To learn more about MicroSalt and MicroSalt® products, please visit www.microsalt.co.

Tekcapital owns 97% of the share capital of MicroSalt Ltd. and 6,034,683 shares (78%) of MicroSalt Inc., its U.S. subsidiary.

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

 

For further information, please contact:

Tekcapital Plc 

 Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon

microsalt@flagstaffcomms.com

 

+44 (0)207 129 1474

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving MicroSalt and/or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of MicroSalt and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties, and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance, or achievements of MicroSalt or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither MicroSalt nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.


[1] https://www.databridgemarketresearch.com/reports/north-america-hazelnut-market

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRALPMRTMTJBBJJ
Date   Source Headline
20th May 20201:51 pmRNSNotification Of Major Shareholding
19th May 202012:07 pmRNSResult of GM and Completion of Fundraise
6th May 20207:00 amRNSFinal Results
1st May 20207:00 amRNSConditional Placing to raise £925,000
29th Apr 202011:05 amRNSSecond Price Monitoring Extn
29th Apr 202011:00 amRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSLucyd expands online presence to Walmart.com
21st Apr 20202:35 pmRNSCorrection : Total Voting Rights
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSMarket Research Report: Belluscura plc
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
9th Apr 20203:27 pmRNSHolding(s) in Company
8th Apr 20207:00 amRNSPortfolio Company Update : Guident
2nd Apr 20207:00 amRNSMexico adopts new Sodium reduction guidelines
30th Mar 20202:54 pmRNSHolding(s) in Company
27th Mar 202012:45 pmRNSHolding(s) in Company
26th Mar 20208:00 amRNSPortfolio Company Update:
26th Mar 20207:00 amRNSPortfolio Company Update: Lucyd
24th Mar 20207:00 amRNSSalarius confirms store roll out
23rd Mar 20202:59 pmRNSPortfolio Company Update
23rd Mar 202010:56 amRNSHolding(s) in Company
16th Mar 20209:15 amRNSBelluscura plc filing of a patent
4th Mar 20207:00 amRNSSalarius secures contract sales partner
2nd Mar 20207:00 amRNSSalarius North American distribution agreement
28th Feb 20207:00 amRNSTotal Voting Rights
12th Feb 20203:09 pmRNSHolding(s) in Company
10th Feb 20202:12 pmRNSHolding(s) in Company
10th Feb 20207:00 amRNSStrategy/Company/Ops Update
7th Feb 20204:03 pmRNSHolding(s) in Company
6th Feb 202012:45 pmRNSPlacing to raise £740,000
24th Jan 20207:00 amRNSSalarius new major food contract
20th Jan 20207:00 amRNSLucyd launch of new bluetooth-enabled Glasses
16th Jan 20207:00 amRNSExhibit At AUTM 2020
7th Jan 20207:00 amRNSAppointment of Director
17th Dec 20197:00 amRNSPortfolio Company Update: Lucyd
12th Dec 20197:00 amRNSPortfolio Company Update
2nd Dec 20191:09 pmRNSBoard Changes
1st Nov 20197:00 amRNSChange of Adviser
16th Oct 20197:00 amRNSPortfolio Company Update
16th Sep 20199:07 amRNSShare Options
2nd Sep 20197:00 amRNSPortfolio Company Update
22nd Aug 20197:00 amRNSHalf-year Report
15th Aug 20197:00 amRNSPortfolio Update: Lucyd Launches Sherman Shades
12th Aug 20197:00 amRNSSalarius Files Additional Patent for MicroSalt®
6th Aug 20197:00 amRNSBelluscura raises £750,000 of additional funding
5th Aug 20193:21 pmRNSHolding(s) in Company - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.